HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bénédicte Rouvière Selected Research

Adrenal Cortex Hormones (Corticosteroids)

1/2022Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis Network.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bénédicte Rouvière Research Topics

Disease

2Uveitis
01/2022 - 01/2022
2Macular Edema
01/2022 - 01/2022
2Autoimmune Diseases (Autoimmune Disease)
01/2021 - 01/2021
1Inflammation (Inflammations)
01/2022
1Retinal Vasculitis
01/2022
1Low Vision (Subnormal Vision)
01/2022
1Rheumatoid Arthritis
01/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021
1Systemic Scleroderma (Systemic Sclerosis)
01/2021

Drug/Important Bio-Agent (IBA)

3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 01/2021
1Adalimumab (Humira)FDA Link
01/2022
1Infliximab (Remicade)FDA Link
01/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022
1tocilizumab (atlizumab)FDA Link
01/2022
1Interleukin-2 (IL2)IBA
01/2021
1CytokinesIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021

Therapy/Procedure

1Therapeutics
01/2021